Explore
Trendline
Hagens Berman Investigates Embecta Corp. for Alleged Securities Law Violations Amid Class Action
Hagens Berman Investigates Embecta Corp. for Alleged Securities Law Violations Amid Class Action
Read More
Trendline
Hagens Berman Investigates Securities Violations at Embecta Corp Amid Class Action
Hagens Berman Investigates Securities Violations at Embecta Corp Amid Class Action
Read More
Trendline
Hagens Berman Investigates Peabody Energy for Alleged Securities Law Violations Amid Class Action
Hagens Berman Investigates Peabody Energy for Alleged Securities Law Violations Amid Class Action
Read More
Trendline
Hagens Berman Investigates Securities Law Violations at Peabody Energy
Hagens Berman Investigates Securities Law Violations at Peabody Energy
Read More
Trendline
Insulet Faces Class Action Lawsuit Over Alleged Securities Fraud
Insulet Faces Class Action Lawsuit Over Alleged Securities Fraud
Read More
Trendline
Pentair plc Faces Securities Fraud Investigation Amid Financial Disclosure Concerns
Pentair plc Faces Securities Fraud Investigation Amid Financial Disclosure Concerns
Read More
Trendline
Investors File Class Action Against EquipmentShare for Alleged Self-Dealing
Investors File Class Action Against EquipmentShare for Alleged Self-Dealing
Read More
Trendline
Lockheed Martin and RTX Stocks Surge Following Strong Q2 Earnings Reports
Lockheed Martin and RTX Stocks Surge Following Strong Q2 Earnings Reports
Read More
Trendline
Citi Upgrades Palantir's Earnings Forecast Amid Anticipated Commercial Growth
Citi Upgrades Palantir's Earnings Forecast Amid Anticipated Commercial Growth
Read More
Trendline
Hagens Berman Investigates IBM for Potential Securities Law Violations After Stock Plunge
Hagens Berman Investigates IBM for Potential Securities Law Violations After Stock Plunge
Read More
Trendline
Kuehn Law Investigates Enphase Energy for Alleged Misrepresentation to Shareholders
Kuehn Law Investigates Enphase Energy for Alleged Misrepresentation to Shareholders
Read More
Trendline
Biotech IPOs Outperform AI Listings with 55% Return
Biotech IPOs Outperform AI Listings with 55% Return
Read More